Tazorac - NDC Database

11 records found
Page:1
0023-0042 Aug 01, 1997
Tazorac 1 mg/g Cutaneous Gel by Allergan, Inc.
0023-3090 Aug 01, 1997
Tazorac 1 mg/g Cutaneous Gel by Allergan, Inc.
0023-3091 Aug 01, 1997
Tazorac .5 mg/g Cutaneous Gel by Allergan, Inc.
0023-8335 Aug 01, 1997
Tazorac .5 mg/g Cutaneous Gel by Allergan, Inc.
0023-9155 Nov 15, 2000
Tazorac .5 mg/g Cutaneous Cream by Allergan, Inc.
0023-9156 Nov 13, 2000
Tazorac 1 mg/g Cutaneous Cream by Allergan, Inc.
16110-042 Feb 21, 2020
Tazorac 1 mg/g Cutaneous Gel by Almirall, LLC
16110-833 Feb 21, 2020
Tazorac .5 mg/g Cutaneous Gel by Almirall, LLC
16110-915 Feb 03, 2020
Tazorac .05 mg/g Cutaneous Cream by Almirall, LLC
16110-916 Feb 03, 2020
Tazorac .1 mg/g Cutaneous Cream by Almirall, LLC
54868-4456 Oct 21, 2010
Tazorac 1 mg/g Oral Gel by Physicians Total Care, Inc.
Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.